113 related articles for article (PubMed ID: 7744118)
1. The usefulness of CD4/CD8 ratio evaluation in monitoring of ovarian cancer patients.
Markowska J; Lacki JK; Jaroszewski J; Wiktorowicz K
Eur J Gynaecol Oncol; 1995; 16(1):54-8. PubMed ID: 7744118
[TBL] [Abstract][Full Text] [Related]
2. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study.
Lacki J; Markowska J; Wiktorowicz K
Eur J Gynaecol Oncol; 1992; 13(6):475-9. PubMed ID: 1473526
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
5. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer.
Wertel I; Polak G; Bednarek W; Barczyński B; Roliński J; Kotarski J
Cytometry B Clin Cytom; 2008 Jul; 74(4):251-8. PubMed ID: 18302193
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
Melioli G; Ferrari I; Casartelli G; Ragni N
Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
[TBL] [Abstract][Full Text] [Related]
9. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
10. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis.
Szyllo K; Tchorzewski H; Banasik M; Glowacka E; Lewkowicz P; Kamer-Bartosinska A
Mediators Inflamm; 2003 Jun; 12(3):131-8. PubMed ID: 12857596
[TBL] [Abstract][Full Text] [Related]
11. Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer.
Kosmas C; Epenetos AA; Courtenay-Luck NS
Cancer; 1994 Jun; 73(12):3000-10. PubMed ID: 8199996
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
14. Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis.
Emad A; Emad Y
Respir Med; 2007 Apr; 101(4):786-92. PubMed ID: 16982181
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.
Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J
Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263
[TBL] [Abstract][Full Text] [Related]
19. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
20. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
